CCO Oncology Podcast

Strategies for Avoiding Adverse Reactions to BTK Inhibitor Therapy, Part 1: Drug–Drug and Drug–Food Interactions

Episode Summary

Listen to Sandra E. Kurtin, PhD, ANP-C, AOCN, discuss managing drug–drug and drug–food interactions to minimize adverse events in patients receiving BTK inhibitors.

Episode Notes

In this podcast episode,Sandra E. Kurtin, PhD, ANP-C, AOCN, discusses nursing perspectives on avoiding adverse reactions to BTK inhibitor therapy. Topics in this first of 2 podcasts on avoiding AEs include:

• Pharmacokinetics
• Drug metabolism
• Drug–drug interactions
• Drug–food interactions
• The role of CYP enzymes
• Foods to avoid
• Medication review

Presenter:

Sandra E. Kurtin, PhD, ANP-C, AOCN
Director, Advanced Practice and Clinical Integration
The University of Arizona Cancer Center
Assistant Professor, Clinical Medicine
Adjunct Clinical Professor, Nursing
The University of Arizona
Tucson, Arizona

CE/AAPA credit available by visiting the online program:
https://bit.ly/3zMXFOp

Link to full program, including downloadable slidesets:
https://bit.ly/3iwN9Ub